These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38331656)
1. Evaluation of the efficacy of probiotics as treatment in irritable bowel syndrome. Ruiz-Sánchez C; Escudero-López B; Fernández-Pachón MS Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):19-30. PubMed ID: 38331656 [TBL] [Abstract][Full Text] [Related]
2. [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea]. Drozdov VN; Shikh EV; Astapovskii AA; Khalaidzheva KN; Solovieva SA; Dorogun OB Vopr Pitan; 2023; 92(4):92-103. PubMed ID: 37801459 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Goodoory VC; Khasawneh M; Black CJ; Quigley EMM; Moayyedi P; Ford AC Gastroenterology; 2023 Nov; 165(5):1206-1218. PubMed ID: 37541528 [TBL] [Abstract][Full Text] [Related]
5. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial. Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935 [TBL] [Abstract][Full Text] [Related]
6. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Andresen V; Gschossmann J; Layer P Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872 [TBL] [Abstract][Full Text] [Related]
7. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials. Zhang WX; Shi LB; Zhou MS; Wu J; Shi HY J Med Microbiol; 2023 Sep; 72(9):. PubMed ID: 37772692 [No Abstract] [Full Text] [Related]
10. [The effects of probiotics on symptoms of irritable bowel syndrome]. Kim YG; Moon JT; Lee KM; Chon NR; Park H Korean J Gastroenterol; 2006 Jun; 47(6):413-9. PubMed ID: 16809947 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials. Shang X; E FF; Guo KL; Li YF; Zhao HL; Wang Y; Chen N; Nian T; Yang CQ; Yang KH; Li XX Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745212 [TBL] [Abstract][Full Text] [Related]
12. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Guglielmetti S; Mora D; Gschwender M; Popp K Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261 [TBL] [Abstract][Full Text] [Related]
13. Review article: probiotics and prebiotics in irritable bowel syndrome. Spiller R Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993 [TBL] [Abstract][Full Text] [Related]
14. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review. Pratt C; Campbell MD Probiotics Antimicrob Proteins; 2020 Sep; 12(3):834-839. PubMed ID: 31741311 [TBL] [Abstract][Full Text] [Related]
16. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. Camilleri M J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702 [TBL] [Abstract][Full Text] [Related]
17. Probiotics in the treatment of irritable bowel syndrome. Saggioro A J Clin Gastroenterol; 2004 Jul; 38(6 Suppl):S104-6. PubMed ID: 15220671 [TBL] [Abstract][Full Text] [Related]
18. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Xie P; Luo M; Deng X; Fan J; Xiong L Nutrients; 2023 Sep; 15(17):. PubMed ID: 37686889 [TBL] [Abstract][Full Text] [Related]
19. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426 [TBL] [Abstract][Full Text] [Related]
20. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial. Sadrin S; Sennoune S; Gout B; Marque S; Moreau J; Zinoune K; Grillasca JP; Pons O; Maixent JM Dig Liver Dis; 2020 May; 52(5):534-540. PubMed ID: 31952938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]